Position in UTHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,881,352
-$4,286,126 QoQ
Shares Held
18,237
-23.7% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#175
of 870 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT CO LTD holds $72,048,993 across 11 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
525,329 | $37,750,141 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
384,707 | $13,033,873 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
18,237 | $9,881,352 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
56,651 | $9,547,959 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
53,978 | $934,359 | |
| 6 | VTRS |
Viatris Inc
|
48,580 | $771,450 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
2,860 | $70,384 | |
| 8 | PRGO |
PERRIGO Co plc
|
2,900 | $30,131 |
All Filings in UTHR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,881,352 | 18,237 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,167,478 | 23,892 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,423,251 | 21,392 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,427,092 | 12,946 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,755,377 | 13,069 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,641,984 | 21,546 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,687,273 | 24,621 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $9,187,018 | 25,637 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $9,093,009 | 28,545 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,137,169 | 31,069 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,815,270 | 30,994 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,200,204 | 23,023 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $7,352,961 | 33,309 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,128,235 | 22,898 | Shares | Sole | 2025-01-10 | |
| 2022-12-31 | $1,778,663 | 6,396 | Shares | Sole | 2025-01-10 | |
| 2022-09-30 | $54,438 | 260 | Shares | Sole | 2025-01-10 | |
| 2022-06-30 | $61,266 | 260 | Shares | Sole | 2025-01-10 | |
| 2022-03-31 | $46,646 | 260 | Shares | Sole | 2025-01-10 | |
| 2021-12-31 | $56,180 | 260 | Shares | Sole | 2025-01-10 | |
| 2021-09-30 | $47,990 | 260 | Shares | Sole | 2025-01-10 | |
| No filing history on record for this holder in this stock. | ||||||